Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Immunoregulatory Activity of the Natural Product Laminarin Varies Widely as a Result of Its Physical Properties.

Smith AJ, Graves B, Child R, Rice PJ, Ma Z, Lowman DW, Ensley HE, Ryter KT, Evans JT, Williams DL.

J Immunol. 2018 Jan 15;200(2):788-799. doi: 10.4049/jimmunol.1701258. Epub 2017 Dec 15.

2.

Novel structural features in Candida albicans hyphal glucan provide a basis for differential innate immune recognition of hyphae versus yeast.

Lowman DW, Greene RR, Bearden DW, Kruppa MD, Pottier M, Monteiro MA, Soldatov DV, Ensley HE, Cheng SC, Netea MG, Williams DL.

J Biol Chem. 2014 Feb 7;289(6):3432-43. doi: 10.1074/jbc.M113.529131. Epub 2013 Dec 16.

3.

New insights into the structure of (1→3,1→6)-β-D-glucan side chains in the Candida glabrata cell wall.

Lowman DW, West LJ, Bearden DW, Wempe MF, Power TD, Ensley HE, Haynes K, Williams DL, Kruppa MD.

PLoS One. 2011;6(11):e27614. doi: 10.1371/journal.pone.0027614. Epub 2011 Nov 11.

4.

Mannan structural complexity is decreased when Candida albicans is cultivated in blood or serum at physiological temperature.

Lowman DW, Ensley HE, Greene RR, Knagge KJ, Williams DL, Kruppa MD.

Carbohydr Res. 2011 Dec 13;346(17):2752-9. doi: 10.1016/j.carres.2011.09.029. Epub 2011 Oct 2.

5.

Synthesis of the beta-1,3-glucan, laminarahexaose: NMR and conformational studies.

Mo KF, Li H, Mague JT, Ensley HE.

Carbohydr Res. 2009 Mar 10;344(4):439-47. doi: 10.1016/j.carres.2008.12.014. Epub 2008 Dec 25.

PMID:
19185288
6.

Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching.

Adams EL, Rice PJ, Graves B, Ensley HE, Yu H, Brown GD, Gordon S, Monteiro MA, Papp-Szabo E, Lowman DW, Power TD, Wempe MF, Williams DL.

J Pharmacol Exp Ther. 2008 Apr;325(1):115-23. doi: 10.1124/jpet.107.133124. Epub 2008 Jan 2.

PMID:
18171906
7.

Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge.

Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, Lockhart BE, Barker LA, Breuel KF, Deponti WK, Kalbfleisch JH, Ensley HE, Brown GD, Gordon S, Williams DL.

J Pharmacol Exp Ther. 2005 Sep;314(3):1079-86. Epub 2005 Jun 23.

PMID:
15976018
8.
9.

Novel monoclonal antibodies with specificity for chelated uranium(VI): isolation and binding properties.

Blake II RC, Pavlov AR, Khosraviani M, Ensley HE, Kiefer GE, Yu H, Li X, Blake DA.

Bioconjug Chem. 2004 Sep-Oct;15(5):1125-36.

PMID:
15366969
10.

Pharmacokinetics of fungal (1-3)-beta-D-glucans following intravenous administration in rats.

Rice PJ, Lockhart BE, Barker LA, Adams EL, Ensley HE, Williams DL.

Int Immunopharmacol. 2004 Sep;4(9):1209-15.

PMID:
15251116
11.

Human monocyte scavenger receptors are pattern recognition receptors for (1-->3)-beta-D-glucans.

Rice PJ, Kelley JL, Kogan G, Ensley HE, Kalbfleisch JH, Browder IW, Williams DL.

J Leukoc Biol. 2002 Jul;72(1):140-6.

PMID:
12101273
12.

Normal human fibroblasts express pattern recognition receptors for fungal (1-->3)-beta-D-glucans.

Kougias P, Wei D, Rice PJ, Ensley HE, Kalbfleisch J, Williams DL, Browder IW.

Infect Immun. 2001 Jun;69(6):3933-8.

13.

Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity.

Tsiapali E, Whaley S, Kalbfleisch J, Ensley HE, Browder IW, Williams DL.

Free Radic Biol Med. 2001 Feb 15;30(4):393-402.

PMID:
11182295
14.

The influence of glucan polymer structure and solution conformation on binding to (1-->3)-beta-D-glucan receptors in a human monocyte-like cell line.

Mueller A, Raptis J, Rice PJ, Kalbfleisch JH, Stout RD, Ensley HE, Browder W, Williams DL.

Glycobiology. 2000 Apr;10(4):339-46.

PMID:
10764821
15.

Receptor binding and internalization of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines.

Müller A, Rice PJ, Ensley HE, Coogan PS, Kalbfleish JH, Kelley JL, Love EJ, Portera CA, Ha T, Browder IW, Williams DL.

J Immunol. 1996 May 1;156(9):3418-25.

PMID:
8617968
16.

Isolation of a previously unidentified polysaccharide (MAR-10) from Hyssop officinalis that exhibits strong activity against human immunodeficiency virus type 1.

Gollapudi S, Sharma HA, Aggarwal S, Byers LD, Ensley HE, Gupta S.

Biochem Biophys Res Commun. 1995 May 5;210(1):145-51.

PMID:
7741735
17.

NMR spectral analysis of a water-insoluble (1-->3)-beta-D-glucan isolated from Saccharomyces cerevisiae.

Ensley HE, Tobias B, Pretus HA, McNamee RB, Jones EL, Browder IW, Williams DL.

Carbohydr Res. 1994 May 20;258:307-11. No abstract available.

PMID:
8039185
18.

Development of a water-soluble, sulfated (1-->3)-beta-D-glucan biological response modifier derived from Saccharomyces cerevisiae.

Williams DL, Pretus HA, McNamee RB, Jones EL, Ensley HE, Browder IW.

Carbohydr Res. 1992 Nov 4;235:247-57.

PMID:
1473107
19.

Development, physicochemical characterization and preclinical efficacy evaluation of a water soluble glucan sulfate derived from Saccharomyces cerevisiae.

Williams DL, Pretus HA, McNamee RB, Jones EL, Ensley HE, Browder IW, Di Luzio NR.

Immunopharmacology. 1991 Nov-Dec;22(3):139-55.

PMID:
1774155
20.

A method for the solubilization of a (1----3)-beta-D-glucan isolated from Saccharomyces cerevisiae.

Williams DL, McNamee RB, Jones EL, Pretus HA, Ensley HE, Browder IW, Di Luzio NR.

Carbohydr Res. 1991 Oct 14;219:203-13.

PMID:
1804535
21.

Isolation, physicochemical characterization and preclinical efficacy evaluation of soluble scleroglucan.

Pretus HA, Ensley HE, McNamee RB, Jones EL, Browder IW, Williams DL.

J Pharmacol Exp Ther. 1991 Apr;257(1):500-10.

PMID:
1902259
22.

External ocular inflammatory effects of lipoxygenase enzyme products.

Napoli SA, Helm C, Insler MS, Ensley HE, Pretus HA, Feigen LP.

Ann Ophthalmol. 1990 Jan;22(1):30-4.

PMID:
2155571
23.

Inhibition of soybean lipoxygenase by SKF 525-A and metyrapone.

Pretus HA, Ignarro LJ, Ensley HE, Feigen LP.

Prostaglandins. 1985 Oct;30(4):591-8.

PMID:
3936118
24.

Reversible inhibitors of beta-glucosidase.

Dale MP, Ensley HE, Kern K, Sastry KA, Byers LD.

Biochemistry. 1985 Jul 2;24(14):3530-9.

PMID:
3929833
25.

Letter: Preparation of an optically active prostaglandin intermediate via asymmetric induction.

Corey EJ, Ensley HE.

J Am Chem Soc. 1975 Nov 12;97(23):6908-9. No abstract available.

PMID:
1184891
26.

Mercuration of , -unsaturated steroidal ketones and other unsaturated systems.

Smith RG, Ensley HE, Smith HE.

J Org Chem. 1972 Dec 29;37(26):4430-5. No abstract available.

PMID:
4642616

Supplemental Content

Loading ...
Support Center